Identification of a determinant within the human immunodeficiency virus 1 surface envelope glycoprotein critical for productive infection of primary monocytes - PubMed (original) (raw)

Comparative Study

Identification of a determinant within the human immunodeficiency virus 1 surface envelope glycoprotein critical for productive infection of primary monocytes

P Westervelt et al. Proc Natl Acad Sci U S A. 1991.

Abstract

Profound differences exist in the replicative capacities of various human immunodeficiency virus 1 isolates in primary human monocytes. To investigate the molecular basis for these differences, recombinant full-length clones were constructed by reciprocal DNA fragment exchange between a molecular clone derived from a monocyte-tropic isolate (ADA) and portions of two full-length clones incapable of infection or replication in primary monocyte cultures (HXB2 and NL4-3). Virions derived from proviral clones that contained ADA sequences encoding vpu and the N and C termini of the surface envelope glycoprotein (gp120) were incapable of replication in monocytes. However, a 283-base-pair ADA sequence encoding amino acids 240-333 of the mature gp120 protein conferred the capacity for high-level virus replication in primary monocytes. The predicted amino acid sequence of this ADA clone differed from NL4-3 and HXB2 at 22 of 94 residues in this portion of gp120, which includes the entire third variable domain. Only 2 of 11 residues implicated in CD4 binding are located in this region of gp120 and are identical in HXB2, NL4-3, and ADA. Alignment of the ADA sequence with published amino acid sequences of three additional monocyte-replicative and three monocyte-nonreplicative clones indicates 6 discrete residues with potential involvement in conferring productive human immunodeficiency virus 1 infection of primary monocytes.

PubMed Disclaimer

Cited by

Mechanisms of HIV-mediated blood-brain barrier compromise and leukocyte transmigration under the current antiretroviral era.
Hernandez C, Gorska AM, Eugenin E. Hernandez C, et al. iScience. 2024 Feb 15;27(3):109236. doi: 10.1016/j.isci.2024.109236. eCollection 2024 Mar 15. iScience. 2024. PMID: 38487019 Free PMC article.
Evolution Driven By A Varying Host Environment Selects For Distinct HIV-1 Entry Phenotypes and Other Informative Variants.
Zhou S, Long N, Swanstrom R. Zhou S, et al. Front Virol. 2023;3:1291996. doi: 10.3389/fviro.2023.1291996. Epub 2023 Nov 16. Front Virol. 2023. PMID: 38239974 Free PMC article.
TZM-gfp cells: a tractable fluorescent tool for analysis of rare and early HIV-1 infection.
Gludish DW, Boliar S, Caldwell S, Tembo DL, Chimbayo ET, Jambo KC, Mwandumba HC, Russell DG. Gludish DW, et al. Sci Rep. 2020 Nov 16;10(1):19900. doi: 10.1038/s41598-020-76422-6. Sci Rep. 2020. PMID: 33199722 Free PMC article.
Alcohol Metabolism Potentiates HIV-Induced Hepatotoxicity: Contribution to End-Stage Liver Disease.
Ganesan M, New-Aaron M, Dagur RS, Makarov E, Wang W, Kharbanda KK, Kidambi S, Poluektova LY, Osna NA. Ganesan M, et al. Biomolecules. 2019 Dec 10;9(12):851. doi: 10.3390/biom9120851. Biomolecules. 2019. PMID: 31835520 Free PMC article.
Incomplete Suppression of HIV-1 by SAMHD1 Permits Efficient Macrophage Infection.
Plitnik T, Sharkey ME, Mahboubi B, Kim B, Stevenson M. Plitnik T, et al. Pathog Immun. 2018;3(2):197-223. doi: 10.20411/pai.v3i2.263. Epub 2018 Dec 6. Pathog Immun. 2018. PMID: 30656243 Free PMC article.

References

1. Cell. 1986 Nov 7;47(3):333-48 - PubMed
1. J Virol. 1986 Aug;59(2):284-91 - PubMed
1. Science. 1987 May 15;236(4803):819-22 - PubMed
1. Cell. 1987 Sep 11;50(6):975-85 - PubMed
1. Science. 1987 Sep 11;237(4820):1351-5 - PubMed

Identification of a determinant within the human immunodeficiency virus 1 surface envelope glycoprotein critical for productive infection of primary monocytes - PubMed (original) (raw)